SELLAS Life Sciences (SLS) Operating Leases (2019 - 2024)
Historic Operating Leases for SELLAS Life Sciences (SLS) over the last 6 years, with Q3 2024 value amounting to $576000.0.
- SELLAS Life Sciences' Operating Leases fell 1055.9% to $576000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $576000.0, marking a year-over-year decrease of 1055.9%. This contributed to the annual value of $460000.0 for FY2023, which is 1972.08% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Operating Leases stood at $576000.0, which was down 1055.9% from $692000.0 recorded in Q2 2024.
- SELLAS Life Sciences' Operating Leases' 5-year high stood at $1.2 million during Q1 2022, with a 5-year trough of $123000.0 in Q1 2020.
- Moreover, its 5-year median value for Operating Leases was $825000.0 (2020), whereas its average is $789263.2.
- As far as peak fluctuations go, SELLAS Life Sciences' Operating Leases crashed by 7388.54% in 2020, and later surged by 67154.47% in 2021.
- SELLAS Life Sciences' Operating Leases (Quarter) stood at $825000.0 in 2020, then dropped by 26.06% to $610000.0 in 2021, then decreased by 6.07% to $573000.0 in 2022, then fell by 19.72% to $460000.0 in 2023, then increased by 25.22% to $576000.0 in 2024.
- Its Operating Leases stands at $576000.0 for Q3 2024, versus $692000.0 for Q2 2024 and $801000.0 for Q1 2024.